Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Actidil
2. Anhydrous, Triprolidine Hydrochloride
3. Hydrochloride Anhydrous, Triprolidine
4. Hydrochloride, Triprolidine
5. Pro Actidil
6. Triprolidine
7. Triprolidine Hydrochloride Anhydrous
8. Triprolidine Monohydrochloride
9. Triprolidine Monohydrochloride, (z)-isomer
10. Triprolidine Monohydrochloride, Monohydrate
11. Triprolidine Oxalate
12. Triprolidine Oxalate, (trans)-isomer
13. Triprolidine, (z)-isomer
1. 550-70-9
2. Actidilat
3. Venen
4. Actidil
5. Trans-triprolidine Hydrochloride
6. Pro-actidil
7. Pro-entra
8. Triprolidine Hydrochloride Anhydrous
9. 6138-79-0
10. Entra
11. (e)-2-(3-(pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridine Hydrochloride
12. Triprolidine Hydrochloride (anhydrous)
13. Mls000028751
14. Ng7a104r3j
15. Chebi:84119
16. Pyridine, 2-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, Monohydrochloride, (e)-
17. Smr000058521
18. Triprolidine (hydrochloride)
19. Triprolidine Hydrochloride (anh.)
20. Sr-01000075292
21. Einecs 208-985-0
22. Unii-ng7a104r3j
23. Pyridine, 2-((1e)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, Monohydrochloride
24. Prestwick_575
25. Mfcd00039044
26. Opera_id_1214
27. (e)-2-[3-(1-pyrrolidinyl)-1-p-tolylpropenyl]pyridine Hydrochloride
28. Trans-2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)pyridine Monohydrochloride
29. Schembl42145
30. Mls001148254
31. Mls002207213
32. Mls002222226
33. Spectrum1500598
34. Chembl1200450
35. Hy-b1808a
36. Dtxsid10872513
37. Hms1568f06
38. Hms1921i07
39. Hms3411o04
40. Hms3675o04
41. Pharmakon1600-01500598
42. Triprolidine Hydrochloride, >=99%
43. Tox21_501130
44. Ccg-40331
45. Nsc757361
46. Triprolidine Monohydrochloride (anh.)
47. Akos015962154
48. Lp01130
49. Triprolidine Monohydrochloride Anhydrous
50. Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, Monohydrochloride, (e)-
51. Ncgc00094397-01
52. Ncgc00094397-02
53. Ncgc00094397-03
54. Ncgc00261815-01
55. Ac-15905
56. As-13971
57. Triprolidine Monohydrochloride (anhydrous)
58. Anhydrous Triprolidine Hydrochloride
59. Triprolidine Hydrochloride [who-dd]
60. Cs-0013855
61. Eu-0101130
62. T 6764
63. 138t790
64. A868718
65. A923663
66. Anhydrous Triprolidine Hydrochloride [mart.]
67. Sr-01000075292-1
68. Sr-01000075292-3
69. Sr-01000075292-7
70. Triprolidine Hydrochloride, Sigma Reference Standard
71. Q27157492
72. (e)-2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)pyridine Monohydrochloride
73. (e)-2-(3-(pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridinehydrochloride
74. (e)-2-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]pyridine Hydrochloride
75. 1-[(2e)-3-(4-methylphenyl)-3-(pyridin-2-yl)prop-2-en-1-yl]pyrrolidinium Chloride
76. 2-[(1e)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridine Hydrochloride
Molecular Weight | 314.9 g/mol |
---|---|
Molecular Formula | C19H23ClN2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 4 |
Exact Mass | 314.1549764 g/mol |
Monoisotopic Mass | 314.1549764 g/mol |
Topological Polar Surface Area | 16.1 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 336 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Triprolidine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Triprolidine Hydrochloride, including repackagers and relabelers. The FDA regulates Triprolidine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Triprolidine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Triprolidine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Triprolidine Hydrochloride supplier is an individual or a company that provides Triprolidine Hydrochloride active pharmaceutical ingredient (API) or Triprolidine Hydrochloride finished formulations upon request. The Triprolidine Hydrochloride suppliers may include Triprolidine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Triprolidine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Triprolidine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Triprolidine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Triprolidine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Triprolidine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Triprolidine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Triprolidine Hydrochloride USDMF includes data on Triprolidine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Triprolidine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Triprolidine Hydrochloride suppliers with USDMF on PharmaCompass.
A Triprolidine Hydrochloride written confirmation (Triprolidine Hydrochloride WC) is an official document issued by a regulatory agency to a Triprolidine Hydrochloride manufacturer, verifying that the manufacturing facility of a Triprolidine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Triprolidine Hydrochloride APIs or Triprolidine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Triprolidine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Triprolidine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Triprolidine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Triprolidine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Triprolidine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Triprolidine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Triprolidine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Triprolidine Hydrochloride suppliers with NDC on PharmaCompass.
Triprolidine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Triprolidine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Triprolidine Hydrochloride GMP manufacturer or Triprolidine Hydrochloride GMP API supplier for your needs.
A Triprolidine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Triprolidine Hydrochloride's compliance with Triprolidine Hydrochloride specifications and serves as a tool for batch-level quality control.
Triprolidine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Triprolidine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Triprolidine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Triprolidine Hydrochloride EP), Triprolidine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Triprolidine Hydrochloride USP).
LOOKING FOR A SUPPLIER?